Unit
- Serotonin (5-HT): Modulates mood, appetite, sleep, and impulse control. Dysregulation is linked to depression, anxiety, and obsessive-compulsive disorder. Medications like SSRIs increase synaptic serotonin by blocking reuptake transporters.
- Dopamine: Regulates reward, motivation, motor control, and executive function. Overactivity in mesolimbic pathways is associated with positive symptoms of schizophrenia; underactivity in prefrontal cortex relates to negative and cognitive symptoms.
- Norepinephrine: Influences arousal, attention, and the fight-or-flight response. Imbalances are implicated in depression, anxiety, and ADHD. SNRIs target both serotonin and norepinephrine reuptake.
- Gamma-aminobutyric acid (GABA): The primary inhibitory neurotransmitter. Reduced GABA function is seen in anxiety disorders, insomnia, and epilepsy. Benzodiazepines enhance GABA-A receptor activity to produce sedation and anxiolysis.
- Glutamate: The major excitatory neurotransmitter, vital for learning and memory. Excessive glutamate activity can cause excitotoxicity, linked to mood disorders and neurodegeneration. Ketamine, an NMDA receptor antagonist, shows rapid antidepressant effects.
- Acetylcholine: Mediates cognitive function, particularly memory and attention. Cholinergic deficits are hallmark of Alzheimer's disease. Anticholinergic side effects from many psychotropics can impair cognition.
- Histamine: Involved in wakefulness and appetite. Antihistaminergic properties of many psychotropics contribute to sedation and weight gain. H1 receptor blockade is a common side effect mechanism.
- Neuropeptides and other modulators: Substances like corticotropin-releasing factor and substance P influence stress response and pain. They represent emerging targets for novel psychopharmacological treatments.
- Orexin (Hypocretin): Regulates arousal, wakefulness, and appetite. Dysregulation contributes to narcolepsy and hypersomnia. Suvorexant, an orexin receptor antagonist, is used for insomnia by promoting sleep initiation and maintenance without typical GABAergic side effects.
- Endocannabinoids: Modulate mood, pain perception, appetite, and stress responses by acting on CB1 and CB2 receptors. They are part of a retrograde signaling system. The endocannabinoid system is a target for anxiety, chronic pain, and substance use disorder treatments.
Scope of Practice
Role: Behavioral Health Coordinator in an Outpatient Mental Health Clinic
Within scope:
- Document patient-reported symptoms and medication changes in electronic health records.
- Educate patients on basic neurotransmitter function and how medications aim to restore balance.
- Communicate observed symptom patterns to the prescribing clinician for treatment adjustments.
- Coordinate referrals for psychotherapy and psychosocial interventions alongside medication management.
Outside scope:
- Interpreting neurotransmitter levels from lab tests or making diagnoses based on symptoms.
- Recommending specific medications or dosages to patients or families.
- Adjusting medication regimens without prescriber authorization.
- Providing genetic testing interpretations related to neurotransmitter pathways.
Terminology
- Neurotransmitter
- A chemical messenger that transmits signals across a synapse from one neuron to another target neuron, muscle cell, or gland cell.
- Reuptake
- The process by which neurotransmitters are reabsorbed into the presynaptic neuron after signaling, limiting the duration of the signal.
- Agonist
- A substance that binds to a receptor and activates it, producing a biological response similar to the endogenous neurotransmitter.
- Antagonist
- A substance that binds to a receptor but blocks activation, inhibiting the action of the endogenous neurotransmitter.
Quick Revision
- Key neurotransmitters in psychopharmacology include serotonin, dopamine, norepinephrine, GABA, glutamate, acetylcholine, and histamine.
- Each neurotransmitter system is associated with specific mental health conditions and therapeutic targets.
- Psychotropic medications modulate neurotransmitter activity through reuptake inhibition, receptor agonism, or antagonism.
- Understanding these systems enables non-prescribing staff to better monitor treatment effects and communicate with prescribers.